These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20005840)

  • 41. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes.
    Davalos AR; Kawahara M; Malhotra GK; Schaum N; Huang J; Ved U; Beausejour CM; Coppe JP; Rodier F; Campisi J
    J Cell Biol; 2013 May; 201(4):613-29. PubMed ID: 23649808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.
    Maruoka M; Kedashiro S; Ueda Y; Mizutani K; Takai Y
    J Biol Chem; 2017 Apr; 292(17):6895-6909. PubMed ID: 28258213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a nuclear localization signal in suppressor of cytokine signaling 1.
    Baetz A; Koelsche C; Strebovsky J; Heeg K; Dalpke AH
    FASEB J; 2008 Dec; 22(12):4296-305. PubMed ID: 18725457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FM19G11: A new modulator of HIF that links mTOR activation with the DNA damage checkpoint pathways.
    Rodríguez-Jiménez FJ; Moreno-Manzano V; Mateos-Gregorio P; Royo I; Erceg S; Murguia JR; Sánchez-Puelles JM
    Cell Cycle; 2010 Jul; 9(14):2803-13. PubMed ID: 20676050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The SOCS1 KIR and SH2 domain are both required for suppression of cytokine signaling in vivo.
    Doggett K; Keating N; Dehkhoda F; Bidgood GM; Meza Guzman LG; Leong E; Kueh A; Nicola NA; Kershaw NJ; Babon JJ; Alexander WS; Nicholson SE
    Cytokine; 2023 May; 165():156167. PubMed ID: 36934508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour-promoting role of SOCS1 in colorectal cancer cells.
    Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
    Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction.
    Liao MJ; Yin C; Barlow C; Wynshaw-Boris A; van Dyke T
    Mol Cell Biol; 1999 Apr; 19(4):3095-102. PubMed ID: 10082576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The suppressor of cytokine signaling SOCS1 promotes apoptosis of intestinal epithelial cells via p53 signaling in Crohn's disease.
    Cui X; Shan X; Qian J; Ji Q; Wang L; Wang X; Li M; Ding H; Liu Q; Chen L; Zhang D; Ni R
    Exp Mol Pathol; 2016 Aug; 101(1):1-11. PubMed ID: 27236107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lamin B1 loss is a senescence-associated biomarker.
    Freund A; Laberge RM; Demaria M; Campisi J
    Mol Biol Cell; 2012 Jun; 23(11):2066-75. PubMed ID: 22496421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells.
    Ryu JY; Oh J; Kim SM; Kim WG; Jeong H; Ahn SA; Kim SH; Jang JY; Yoo BC; Kim CW; Lee CE
    BMB Rep; 2022 Apr; 55(4):198-203. PubMed ID: 35321782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations.
    Feng Z; Hu W; Teresky AK; Hernando E; Cordon-Cardo C; Levine AJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16633-8. PubMed ID: 17921246
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [SOCS1 knockdown sensitize anti-tumor activity of IFN-alpha2a-NGR].
    Huang QC; Lei XY; Liu Y; Sui WJ; Li S; Zhang YQ; Yan Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):412-5. PubMed ID: 20423643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How phosphorylation controls p53.
    MacLaine NJ; Hupp TR
    Cell Cycle; 2011 Mar; 10(6):916-21. PubMed ID: 21350334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells.
    Parrillas V; Martínez-Muñoz L; Holgado BL; Kumar A; Cascio G; Lucas P; Rodríguez-Frade JM; Malumbres M; Carrera AC; van Wely KH; Mellado M
    Cell Mol Life Sci; 2013 Feb; 70(3):545-58. PubMed ID: 23001011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of Stat5 transcription factors as tumor suppressors or oncogenes.
    Ferbeyre G; Moriggl R
    Biochim Biophys Acta; 2011 Jan; 1815(1):104-14. PubMed ID: 20969928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction and functional interference of glucocorticoid receptor and SOCS1.
    Haffner MC; Jurgeit A; Berlato C; Geley S; Parajuli N; Yoshimura A; Doppler W
    J Biol Chem; 2008 Aug; 283(32):22089-96. PubMed ID: 18524780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caveolin-1, cellular senescence and pulmonary emphysema.
    Volonte D; Galbiati F
    Aging (Albany NY); 2009 Aug; 1(9):831-5. PubMed ID: 20157570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1.
    Bouamar H; Jiang D; Wang L; Lin AP; Ortega M; Aguiar RC
    Mol Cell Biol; 2015 Apr; 35(8):1329-40. PubMed ID: 25645925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SOCS1: phosphorylation, dimerization and tumor suppression.
    Lessard F; Saint-Germain E; Mignacca L; Ferbeyre G
    Oncoscience; 2019 Nov; 6(11-12):386-389. PubMed ID: 31984217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    Yamada C; Ozaki T; Ando K; Suenaga Y; Inoue K; Ito Y; Okoshi R; Kageyama H; Kimura H; Miyazaki M; Nakagawara A
    J Biol Chem; 2010 May; 285(22):16693-703. PubMed ID: 20353948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.